Effects of formulation types on pharmacodynamics of warfarin in patients with cerebral infarction and dysphagia
Young-Ji Kim,1,2 Jong-Woo Jeong,1 Youngshin Song,3 Tae-Sung Koo1 1Graduate School of New Drug Discovey and Development, Chungnam National University, Daejeon 305-764, Republic of Korea; 2Chungnam National University Hospital, Daejeon 305-764, Republic of Korea; 3Department of Nursing, College of Nur...
Saved in:
Main Authors: | Kim YJ (Author), Jeong JW (Author), Song Y (Author), Koo TS (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, on the pharmacokinetics and pharmacodynamics of warfarin
by: Jung JA, et al.
Published: (2015) -
Effect of Daridorexant on the Pharmacokinetics of Midazolam, and on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male Subjects
by: Isabelle Zenklusen, et al.
Published: (2024) -
Pharmacokinetic and pharmacodynamic evaluation according to absorption differences in three formulations of ibuprofen
by: Shin D, et al.
Published: (2017) -
Evaluation of pharmacokinetics of warfarin from validated pharmacokinetic-pharmacodynamic model
by: Kannan Sridharan, et al.
Published: (2021) -
Deriving mechanism‐based pharmacodynamic models by reducing quantitative systems pharmacology models: An application to warfarin
by: Undine Falkenhagen, et al.
Published: (2023)